Roxanne Dryden-Edwards, MD
Dr. Roxanne Dryden-Edwards is an adult, child, and adolescent psychiatrist. She is a former Chair of the Committee on Developmental Disabilities for the American Psychiatric Association, Assistant Professor of Psychiatry at Johns Hopkins Hospital in Baltimore, Maryland, and Medical Director of the National Center for Children and Families in Bethesda, Maryland.
Melissa Conrad Stöppler, MD
Melissa Conrad Stöppler, MD, is a U.S. board-certified Anatomic Pathologist with subspecialty training in the fields of Experimental and Molecular Pathology. Dr. Stöppler's educational background includes a BA with Highest Distinction from the University of Virginia and an MD from the University of North Carolina. She completed residency training in Anatomic Pathology at Georgetown University followed by subspecialty fellowship training in molecular diagnostics and experimental pathology.
In this Article
- Generalized anxiety disorder facts
- What is generalized anxiety disorder (GAD)?
- What are the different types of anxiety?
- How common is generalized anxiety disorder?
- What are causes and risk factors for anxiety?
- What are anxiety symptoms and signs?
- How is generalized anxiety disorder diagnosed?
- What is the treatment for anxiety?
- What are the side effects of anxiety medications?
- What are complications of generalized anxiety disorder?
- Can anxiety be prevented?
- What is the prognosis of generalized anxiety disorder?
- Are there support groups for those with generalized anxiety disorder?
- Where can people find additional information on generalized anxiety disorder?
- Find a local Psychiatrist in your town
What is the prognosis of generalized anxiety disorder?
Generalized anxiety disorder can be quite chronic, in that the average length of time the illness lasts is 20 years if untreated. It can significantly interfere with the lives of individuals who have it and usually requires treatment for it to resolve. Therefore, people with generalized anxiety disorder are usually thought to need treatment for at least a year to prevent its recurrence.
Are there support groups for those with generalized anxiety disorder?
The following are examples of support groups for anxiety disorders:
Inc. (Agoraphobics Building Independent Lives)
(Agoraphobics in Motion)
Freedom From Fear
Where can people find additional information on generalized anxiety disorder?
American Academy of
Child and Adolescent Psychiatry
American Psychiatric Association
American Psychological Association
Anxiety Disorders Association of America
3135 Custer Dr.
Lexington, KY 40517-4001
Association of Social Workers
National Mental Health
National Panic/Anxiety Disorder News, Inc.
Amir N, Beard C, Cobb M, Bomyea J. Attention modification program in individuals with generalized anxiety disorder. Journal of Abnormal Psychology 2009 February; 118(1): 28-33.
Arehart-Treichel J. Anxiety symptoms linked to women's cardiac events. Psychiatric News 2009 December; 44(24): 26-37.
Arehart-Treichel J. Extended GAD treatment keeps relapse rates low. Psychiatric News 2011 February; 46(3): 24.
Baldwin D, Woods R, Lawson R, Taylor D. Efficacy of drug treatments for generalized anxiety disorder: systematic review and meta-analysis. British Medical Journal 2011 March; 342.
Ballenger JC, Davidson JRT, Lecrubier Y, Nutt DJ, et al. Consensus statement on generalized anxiety disorder from the international consensus group on depression and anxiety. Journal of Clinical Psychiatry 2001; 62(suppl 11): 53-58.
Beesdo K, Knappe S, Pine DS. Anxiety and anxiety disorders in children and adolescents: developmental issues and implications for DSM-V. Psychiatric Clinics of North America 2009 September; 32(3): 483-524.
Blumenthal H, Leen-Feldner EW, Babson KA, Gahr JL, Trainor CD, Frala JL. Elevated social anxiety among early maturing girls. Developmental Psychology 2011 July; 47(4): 1133-1140.
Bystritsky A, Kerwin L, Feusner JD, Vapnik T. A pilot controlled trial of buproprion XL vs. escitalopram in generalized anxiety disorder (GAD). Pscychopharmacology Bulletin 2008; 41(1): 1-9.
Cuthbert B. Early prevention in childhood anxiety disorders. American Journal of Psychiatry 2010; 167:1428-1430.
Fava M, Asnis GM, Shrivastava R, Lydiard B, et al. Zolpidem extended-release improves sleep and next-day symptoms in comorbid insomnia and generalized anxiety disorder. Journal of Clinical Psychopharmacology 2009 June; 29(3): 222-230.
Flint A, Peasley-Miklus C, Papademetriou E, et al. Effect of age on the frequency of anxiety disorders in major depression with psychotic features. American Journal of Geriatric Psychiatry 2010 May; 18 (5): 404-412.
Grant BF, Hasin DS, Blanco C, Stinson FS, et al. The epidemiology of social anxiety disorder in the United States: results from the national epidemiologic survey on alcohol and related conditions. Journal of Clinical Psychiatry 2005 November; 66(11): 1351-1361.
Hammond DC. Hypnosis in the treatment of anxiety- and stress-related disorders. Expert Review of Neurotherapy 2010 February; 10(2): 263-273.
Herring MP, O'Connor PJ, Dishman RK. The effect of exercise training on anxiety symptoms among patients: a systemic review. Archives of Internal Medicine 2010 February; 170(4): 321-331.
Johnson JG, Cohen P, Pine DS, et al. Association between cigarette smoking and anxiety disorders during adolescence and early adulthood. Journal of the American Medical Association 2000; 284: 2348-2351.
Kalra SK, Swedo SE. Children with obsessive-compulsive disorder: are they just "little adults?" Journal of Clinical Investigation 2009; 119(4): 737-746.
Merikangas KR, He JP, Brody D, Fisher PW, et al. Prevalence and treatment of mental disorders among U.S. children in the 2001-2004 NHANES. Pediatrics 2010 January; 125(1): 75-81.
McLaughlin KA, Hatzenbuehler ML. Stressful life events, anxiety sensitivity, and internalizing symptoms in adolescents. Journal of Abnormal Psychology 2009 August; 118(3): 659-669.
Nasreen HE, Kabir ZN, Forsell Y, Edhborg M. Low birth weight in offspring of women with depressive and anxiety symptoms during pregnancy: results from a population based study in Bangladesh. Biomed Central Public Health 2010; 10: 515.
Pande AC, Pollack MH, Crockatt J, Greiner M, Chouinard G, et al. Placebo-controlled study of gabapentin treatment of panic disorder. Journal of Clinical Psychopharmacology 2000 August; 20(4): 467-471.
Piacentini J, Roblek T. Recognizing and treating childhood anxiety disorders. Western Journal of Medicine 2002 May; 176(3): 149-151.
Pincus DB, May JE, Whitton SW, Mattis SG, Barlow DH. Cognitive-behavioral treatment of panic disorder in adolescence. Journal of Clinical Child and Adolescent Psychology 2010 Sep; 39(5): 638-49.
Rapee RM. The development and modification of temperamental risk for anxiety disorders: prevention of a lifetime of anxiety? Biological Psychiatry 2002 November; 52(10): 947-957.
Rickels K, Pollack MH, Sheehan DV, Haskins JT. Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder. American Journal of Psychiatry 2000; 157: 968-974.
Saeed SA, Bloch RM, Antonacci DJ. Herbal and dietary supplements for treatment of anxiety disorders. American Family Physician 2007 Aug 15; 76(4): 549-56.
Soto JA, Dawson-Andoh NA, BeLue R. The relationship between perceived discrimination and generalized anxiety disorder among African Americans, Afro Caribbeans and non-Hispanic Whites. Journal of Anxiety Disorders 2011 March; 25(2): 258-265.
Trivedi JK, Gupta PK. An overview of Indian research in anxiety disorders. Indian Journal of Psychiatry 2010; 52(7): 210-218.
White SW, Ollendick T, Scahill L, Oswald D, Albano AM. Preliminary efficacy of a cognitive-behavioral treatment program for anxious youth with autism spectrum disorders. Journal of Autism and Developmental Disorders 2009 June.
Last Editorial Review: 4/12/2012
Viewers share their comments
Get tips on therapy and treatment.